IAMGOLD CORP (IAG)       2.7  -0.01 (-0.37%)

2.7  -0.01 (-0.37%)

CA4509131088 - Common Stock - After market: 2.69 -0.01 (-0.37%)


Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IAG. IAG was compared to 969 industry peers in the Metals & Mining industry. Both the profitability and financial health of IAG have multiple concerns. While showing a medium growth rate, IAG is valued expensive at the moment.

Note: IAG has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of IAG is 5.00. This is a neutral score and indicates average health and profitability for IAG.

VS Industry

Valuation

Valuation Rating

3

When comparing the current price to the book value of IAG, it is valued rather cheaply. It is trading at 0.61 times its book value.
Compared to an average industry price book ratio of 1.68, IAG is valued rather cheaply. On top of this, IAG is cheaper than 83% of the companies listed in the same industry.
Compared to an average industry Enterprise Value to EBITDA ratio of 6.23, IAG is valued in line with its industry peers.

IAG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IAG. No positive earnings are expected for the next year.
VS Industry

Price/Book (0.61) VS Industry: 83% outperformed.

6,836.00
0.03

Enterprise Value/ EBITDA (4.77) VS Industry: 60% outperformed.

374.61
0.07

Growth

Growth Rating

6

IAG is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 209.94% yearly.
Looking at the last year, IAG shows a very strong growth in Revenue. The Revenue has grown by 127.61%.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The Revenue has been decreasing by -2.62% on average over the past 5 years.
Based on estimates for the next 5 years, IAG will show a small growth in Revenue. The Revenue will grow by 0.99% on average per year.
The earnings per share for IAG have decreased strongly by -120.00% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -120% -630.23% 456.53% 209.94% N/A
Revenue-2.62% -3.45% 127.61% -37.13% -2.07% 0.99% N/A

Health

Health Rating

3

A Current Ratio of 2.35 indicates that IAG has no problem at all paying its short term obligations.
IAG has a Quick Ratio of 2.04. This indicates that IAG is financially healthy and has no problem in meeting its short term obligations.
IAG has a Current Ratio comparable to the industry average, which is at 2.56.
The Quick Ratio is in line with the industry averages, which is at 2.16.

IAG has a Piotroski-F score of 5.00. This indicates an average health and profitability for IAG.
IAG has one of the worst Debt to Equity ratios in its industry. 94% of its industry peers require less debt for financing their operations.
Based on the Altman-Z score of 0.94, we must say that IAG is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of IAG to the average industry Altman-Z score of 2.51, IAG is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0.46) VS Industry: 6% outperformed.

4.14
0.00

Quick Ratio (2.04) VS Industry: 48% outperformed.

0.00
178.59

Current Ratio (2.35) VS Industry: 46% outperformed.

0.00
178.59

Altman-Z (0.94) VS Industry: 38% outperformed.

-22,403.48
2,514.55

Dividend

Dividend Rating

0

IAG does not give a dividend.

IAMGOLD CORP2.7

NYSE:IAG (3/29/2023, 7:12:58 PM)-0.01 (-0.37%)

After market: 2.69 -0.01 (-0.37%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-16 2023-02-16/amc
Earnings (Next)05-01 2023-05-01/amc
Inst Owners48.16%
Inst Owner Change-2.89%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.29B
Analysts69.23
Price Target2.9 (7.41%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-940.51%
Min EPS beat(2)-1880.2%
Max EPS beat(2)-0.82%
EPS beat(4)1
Avg EPS beat(4)-453.18%
Min EPS beat(4)-1880.2%
Max EPS beat(4)211.55%
Revenue beat(2)2
Avg Revenue beat(2)85.09%
Min Revenue beat(2)14.12%
Max Revenue beat(2)156.05%
Revenue beat(4)3
Avg Revenue beat(4)42.84%
Min Revenue beat(4)-4.49%
Max Revenue beat(4)156.05%
PT rev (1m)-4.28%
PT rev (3m)19.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-400%
EPS NY rev (1m)-483.06%
EPS NY rev (3m)-483.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.59%
Revenue NY rev (1m)-4.59%
Revenue NY rev (3m)-4.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF 3.52
P/B 0.61
P/tB 0.61
EV/EBITDA 4.77
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)0.77
OCFY28.45%
SpS4.16
BVpS4.45
TBVpS4.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.19%
ROICexc 3.58%
ROICexgc 3.58%
OM 7.66%
PM N/A
GM 15.46%
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.37%
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5Y-2.37%
OM growth 3YN/A
OM growth 5Y3.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.16%
GM growth 5Y2.01%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA 2.52
Cap/Depr 307.69%
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.04
Altman-Z 0.94
F-Score5
WACC9.55%
ROIC/WACC0.37
Cap/Depr(3y)198.53%
Cap/Depr(5y)160.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-120%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-122.22%
EPS Next Y-630.23%
EPS Next 2Y456.53%
EPS Next 3Y209.94%
EPS Next 5YN/A
Revenue growth 1Y127.61%
Revenue growth 3Y-3.45%
Revenue growth 5Y-2.62%
Revenue growth Q2Q5110.87%
Revenue Next Year-37.13%
Revenue Next 2Y-2.07%
Revenue Next 3Y0.99%
Revenue Next 5YN/A
EBIT growth 1Y353.91%
EBIT growth 3YN/A
EBIT growth 5Y0.31%
EBIT Next Year349.75%
EBIT Next 3Y130.44%
EBIT Next 5YN/A
FCF growth 1Y-11.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.09%
OCF growth 3Y0.45%
OCF growth 5Y4.49%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA